Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pharming (PHAR) Interest Expenses (2020 - 2021)

Historic Interest Expenses for Pharming (PHAR) over the last 2 years, with Q4 2021 value amounting to -$5.2 million.

  • Pharming's Interest Expenses fell 12505.56% to -$5.2 million in Q4 2021 from the same period last year, while for Sep 2022 it was -$5.2 million, marking a year-over-year decrease of 12505.56%. This contributed to the annual value of $8511.1 for FY2021, which is 12618.77% up from last year.
  • Latest data reveals that Pharming reported Interest Expenses of -$5.2 million as of Q4 2021, which was down 12505.56% from $20.9 million recorded in Q4 2020.
  • Over the past 5 years, Pharming's Interest Expenses peaked at $20.9 million during Q4 2020, and registered a low of -$5.2 million during Q4 2021.